NCT07153432

Brief Summary

The goal of this observational study is to assess epidemiology of chronic kidney disease in patients followed at a tertiary care center. The main question it aims to answer is: What is the proportion of patients with chronic kidney disease overall and how many are previously undiagnosed.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
3,000

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Feb 2025

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 24, 2025

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

August 6, 2025

Completed
29 days until next milestone

First Posted

Study publicly available on registry

September 4, 2025

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 19, 2025

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

January 31, 2026

Completed
Last Updated

September 4, 2025

Status Verified

August 1, 2025

Enrollment Period

8 months

First QC Date

August 6, 2025

Last Update Submit

August 29, 2025

Conditions

Chronic Kidney Diseases

Keywords

chronic kidney diseasescreeningepidemiology

Outcome Measures

Primary Outcomes (1)

  • Proportion of patients with chronic kidney disease

    Chronic kidney disease diagnosed with either decreased estimated glomerular filtration rate and/or increased albumin excretion in urine

    Baseline

Study Arms (2)

Case group

Control group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Adult patients followed at the Institute for Clinical and Experimental Medicine

You may qualify if:

  • age \> 50 or age \>18 + one of these conditions (history of diabetes, arterial hypertension, ischemic heart disease, stroke, perpheral artery disease, atrial fibrillation, heart failure)
  • agree to participate
  • followed at the Institute for Clinical and Experimental Medicine

You may not qualify if:

  • unwilling to participate
  • kidney transplant recipient/previous kidney transplantation

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Institute for Clinical and Experimental Medicine

Prague, 14021, Czechia

RECRUITING

MeSH Terms

Conditions

Renal Insufficiency, Chronic

Condition Hierarchy (Ancestors)

Renal InsufficiencyKidney DiseasesUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital DiseasesChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Central Study Contacts

Ivan Zahradka, MD

CONTACT

+420261364110zahi@ikem.cz

Vojtech Petr, MD

CONTACT

petv@ikem.cz

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER GOV
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Head of Department

Study Record Dates

First Submitted

August 6, 2025

First Posted

September 4, 2025

Study Start

February 24, 2025

Primary Completion

October 19, 2025

Study Completion

January 31, 2026

Last Updated

September 4, 2025

Record last verified: 2025-08

Locations

CZ(1)